<DOC>
<DOCNO>EP-0621037</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Pyrido-pyrimidinediones, process for their preparation and their use as pharmaceuticals
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K31495	A61K31495	A61P700	A61P702	A61P900	A61P900	A61P908	A61P910	A61P2500	A61P2518	A61P2528	A61P4300	A61P4300	C07D47100	C07D47104	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61P	A61P	A61P	A61P	A61P	A61P	A61P	A61P	A61P	A61P	A61P	C07D	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61K31	A61P7	A61P7	A61P9	A61P9	A61P9	A61P9	A61P25	A61P25	A61P25	A61P43	A61P43	C07D471	C07D471	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
A compound of the formula I 
<
IMAGE
>
 and/or physiologically tolerated salts of the compound of the formula I and/or where appropriate stereoisomeric forms of the compound of the formula I are suitable for producing pharmaceuticals for the treatment of disturbances of blood flow and/or neurodegenerative disorders.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
HOECHST AG
</APPLICANT-NAME>
<APPLICANT-NAME>
HOECHST AKTIENGESELLSCHAFT
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
FURRER HARALD DR
</INVENTOR-NAME>
<INVENTOR-NAME>
GROME JOHN JOSEPH DR
</INVENTOR-NAME>
<INVENTOR-NAME>
OKYAYUZ-BAKLOUTI ISMAHAN DR
</INVENTOR-NAME>
<INVENTOR-NAME>
SEIFFGE DIRK DR
</INVENTOR-NAME>
<INVENTOR-NAME>
FURRER, HARALD, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
GROME, JOHN JOSEPH, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
OKYAYUZ-BAKLOUTI, ISMAHAN, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
SEIFFGE, DIRK, DR.
</INVENTOR-NAME>
</INVENTORS>
</TEXT>
</DOC>
